5 June 2025 - 6 June 2025
4051 Basel, Switzerland
Viaduktstrasse 31-35
VIA Basel
World Drug Safety Summit
OUR STORY TO TELL THE WORLD
OUR CONFERENCE PROGRAM
This is not just another Drug Safety conference. This is a conference which tells you a STORY.
One personal experience followed by another, a storyline of exceptional people who happen to choose Drug Safety and Pharmacovigilance as their way to bring needed medicines and protect those who are the most vulnerable, and improve the health of millions of people on our planet.
You will hear experts talk about the current issues in this ever-evolving industry:
-
The best practice case studies on how to integrate new, disruptive technology into the rather rigid processes of PV organization and how it evolves to stay compliant.
-
But how to do this with the more and more restrictive budget?
-
How to prioritize, what methodologies to use for advanced therapies?
-
What is the next evolution step in signal detection noise clearance?
-
Are AI-based tools to become our colleagues, helpmates, or our replacement?
Nonetheless, each company, department, and project starts with people.
-
But how to build a winning cross-functional team and what kind of workforce is necessary for a drug safety department of the future?
-
What kind of skills to expect from millennials and Gen-Z entering the industry?
-
Why do we need veterans in the industry as well?
Challenges with:
-
Innovations
-
Outsourcing
-
Everchanging regulatory landscape
-
Harmonization
-
Teaching other departments how to use RWE data
-
Engaging the more and more aware public
All these topics we address, are conveyed having our mission in our mind:
Bringing medicines and new therapeutic indications to patients, faster, safer, and more sustainably.
Our visionary keynote presentations and best practice case studies will complement engaging panel discussions with different speakers to better understand Pharmacovigilance challenges and solutions from different perspectives, with unique views coming from some of the most experienced and passionate professionals.
Our conference will feature numerous assisted formal and informal:
-
Networking
-
Matchmaking
-
Breakout sessions
...to create those critical business friendships that will bring fruitful cooperation and fill that missing piece in our common mission to improve drug safety and quality of life for all.
Always ask WHY?
Creating contrast to loud, expo-style meetings with limited focus and personal touch, WHY SUMMITS World tour of Pharmacovigilance conferences brings another kind of experience. Our Basel concentrated knowledge-focused meeting is assembled in 8 blocks focusing on:
-
Real-world implementation of Patient-centric Drug Safety strategies
-
Low-end digital disruptions in PV: improving lives while cutting costs
-
Advancements in Benefit-Risk assessment and aRMMs
-
Post-Trial Access and Clinical Safety
-
Multidepartment collaboration towards better safety and commercial outcomes
-
Regulatory Affairs in Drug Safety
-
Innovative approach in signal detection & reporting automation
-
Role of Pharmacovigilance in data-driven pharmaceutical business
-
Comprehensive compliance updates in European Pharmaceutical Safety
SPEAKERS
Sanjeev Srivastav
Signal Management Lead | BionTech
Michael von Forstner
Head of Safety Science | SOBI
Petros Mavrogenis
Head Vigilance Process Excellence | Novartis
Luvanka Hanxhari
Adriano Galati
Jost Leemhuis
Patient Safety Partner | Roche
Elena Radu
Senior Drug Safety Physician | Basilea Pharmaceutica
Marjan Dzeparoski
PV Manager & University lecturer | Bionika
Mircea Ciuca
Global Head Medical Safety | Organon
Monika Zych
PS Director, CEEI&META, UKI & Nordics, DACH | Baxter
Sabine Poltermann
Remco M. Diab
Etienne Raemy
Head of Pharmacovigilance | Debiopharm Research & Manufacturing
Abdul Rahim
Founder & Director | Alwis
Marija Simic Koumoutsaris
Director Medical Safety | Sandoz
Jean Redmond
COO | Biologit
Marianne Soergel-Ahovi
Head Drug Safety | Molecular Partners
Iva Mandic
Associate Safety Director | Roche
Nikoletta Militsi
LQPPV Network Functional Lead | IQVIA
You will spend your time with:
-
Drug safety & Pharmacovigilance executives
-
Heads of global safety programs
-
QPPVs
-
Benefit-Risk assessment management
-
Medical affairs management
-
Patient safety management
-
Compliance specialists
-
Post-market researchers
-
PV auditors
-
Regulatory affairs directors
-
EMA professionals
-
Compliance specialists
-
Pharma IT management
-
Safety consultants
FLOOR PLAN
TESTIMONIALS
Christine Clearwater
”Unlike some other similar events, I found relevance in every session within your conference. The content was neither too simplistic nor too advanced. The participants and presenters provided a diverse view of the issues that are present for most in this industry.”
Manager, Safety Operations and Vendor Management, Global Patient Safety | Baxter
Sameer Thapar
“Great dialogue on key issues. Everyone shared truthful insight and did not hold back, even on negative experiences.”
Assistant Professor & Advisor, Drug Safety and Pharmacovigilance | Rutgers University
Daniel Naranjo
“Loved it. It was very practical and provided valuable insight into practical methods that are actionable for patient safety.”
Global Safety Lead, Global Patient Safety Evaluation | Takeda
CONTACT US
Jan Cizek | SPEAKING | COORDINATION
-
e-mail: jan.cizek@whysummits.com
-
LinkedIn: Jan Cizek
Rakesh Multani | ATTENDING AND SPONSORING
-
e-mail: rakesh@whysummits.com
-
LinkedIn: Rakesh Multani
Lubos Kusy | ATTENDING AND SPONSORING
-
e-mail: lubos@whysummits.com
-
LinkedIn: Lubos Kusy